Why the study?
Guidelines suggest traditional Chinese medicine as an adjunct in chronic heart failure, but more convincing clinical evidence is needed for therapies like Linggui Zhugan decoction.
Does Linggui Zhugan decoction improve NT-proBNP and LVEF in adults with chronic heart failure and Yang deficiency?
Population
Patients with chronic heart failure and Yang deficiency
Comparison
Linggui Zhugan decoction vs comparator not specified
Design
Systematic review and meta-analysis protocol of randomized controlled trials
Authors
Loading...
Supports adjunct LGZGD for Yang-deficient CHF; extends RCT evidence for TCM integration in guidelines.
Does Linggui Zhugan decoction improve NT-proBNP and LVEF in adults with chronic heart failure and Yang deficiency?
This protocol outlines a planned systematic review and meta-analysis to evaluate the efficacy and safety of Linggui Zhugan decoction as an adjunct therapy for chronic heart failure with Yang deficiency.
Li et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: